• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NovaBay Pharmaceuticals Inc

+ Add to Watchlist


0.502 EUR 0.007 1.41%

As of 02:08:32 ET on 12/18/2014.

Snapshot for NovaBay Pharmaceuticals Inc (B9P)

Open: 0.502 Day's Range: 0.502 - 0.502 Volume: 0
Previous Close: 0.495 52wk Range: 0.449 - 0.989 1-Yr Rtn: -40.80%

Stock Chart for B9P

No chart data available.
  • B9P:GR 0.502
  • 1M
  • 1Y
Interactive B9P Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for B9P

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3000
Est. PEG Ratio -
Market Cap (M EUR) 25.92
Shares Outstanding (M) 51.63
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for B9P

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for B9P

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay Pharmaceuticals has developed a class of antimicrobial compounds for use in the treatment and prevention of bacterial infections.

Ramin Najafi "Ron"Chairman/President/CEOThomas J PaulsonCFO/Treasurer/Secretary
Roy J WuSenior VP:Bus & Corp DevDavid W StromanSenior VP:Ophthalmic Product Dev
More Company Profile & Key Executives for B9P

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil